Melodi Health Announces $10.75 Million in Series A Funding, First Enrollment in Pivotal Clinical Trial Katie Lew · August 29, 2024
August 29, 2024 Melodi Health Announces $10.75 Million in Series A Funding, First Enrollment in Pivotal Clinical TrialGround-breaking investigational product from Melodi Health is designed to reduce post-surgical infections
August 27, 2024 NeuraWorx Partners with Corundum Neuroscience to Initiate Clinical Feasibility Study, Develop Innovative Neurological Disease TreatmentEXCELSIOR, Minn. – Aug. 27, 2024 – PRLog — NeuraWorx Medical Technologies, Inc., a neurotechnology therapeutics company, announced
August 27, 2024 Biocoat Incorporated Secures New Patent for Non-PFAS Inner Diameter CoatingHorsham, PA, [August 27, 2024] – Biocoat Incorporated, a leader in the
News, Press ReleaseFairview Welcomes Tanja Oquendo as New Chief People Officer Katie LewJuly 9, 2024 Fairview Welcomes Tanja Oquendo as New Chief People Officer
News, Press ReleaseSTERIS Announces New Ethylene Oxide Processing Facility in Singapore Katie LewJuly 9, 2024 STERIS Announces New Ethylene Oxide Processing Facility in Singapore
News, Press ReleaseLEAH Labs and University of Missouri Launch Trial Funded by National Cancer Institute Aimed at Visualizing CAR-T Cell Therapy in Pet Dogs with Cancer Katie LewJuly 8, 2024 LEAH Labs and University of Missouri Launch Trial Funded by National Cancer Institute Aimed at Visualizing CAR-T Cell Therapy in Pet Dogs with Cancer
ArticlesFor the Record with David Gramer, Founder and Principal Consultant, Prism Compensation Consulting Katie LewJuly 8, 2024 For the Record with David Gramer, Founder and Principal Consultant, Prism Compensation Consulting